Neoadjuvant and adjuvant therapy for extremity soft tissue sarcomas

Hematology/Oncology Clinics of North America

Volumn 19, Issue 3, 2005, Pages 489-500

  Scurr, Michelle ^a   Judson, Ian ^a,b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; EPIRUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; METHOTREXATE; VINCRISTINE;

CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; CONVALESCENCE; DEATH; DRUG DETERMINATION; DRUG FATALITY; DRUG SAFETY; ERADICATION THERAPY; HEAD AND NECK TUMOR; HIGH RISK PATIENT; HUMAN; LIMB TUMOR; LIPOSARCOMA; METASTASIS; MICROSCOPY; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; REVIEW; SOFT TISSUE SARCOMA; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; EXTREMITIES; HUMANS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SOFT TISSUE NEOPLASMS;

EID: 20444408421     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2005.03.003     Document Type: Review

References (60)

1. A. Stojadinovic, D.H. Leung, and P. Allen Primary adult soft tissue sarcoma: time-dependent influence of prognostic variables J Clin Oncol 20 21 2002 4344 4352
2. Sarcoma Meta-analysis Collaboration Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data Lancet 350 9092 1997 1647 1654
3. J. Weitz, C.R. Antonescu, and M.F. Brennan Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time J Clin Oncol 21 14 2003 2719 2725
4. R.T. Greenlee, M.B. Hill-Harmon, and T. Murray Cancer statistics, 2001 CA Cancer J Clin 51 1 2001 15 36
5. L. Norton Adjuvant breast cancer therapy: current status and future strategies-growth kinetics and the improved drug therapy of breast cancer Semin Oncol 26 1 Suppl 3 1999 1 4
6. J.H. Goldie, and A.J. Coldman A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate Cancer Treat Rep 63 11-12 1979 1727 1733
7. F.C. Eilber, G. Rosen, and J. Eckardt Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas J Clin Oncol 19 13 2001 3203 3209
8. F. Meric, K.R. Hess, and D.G. Varma Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas Cancer 95 5 2002 1120 1126
9. P.W. Pisters, S.R. Patel, and D.G. Varma Preoperative chemotherapy for stage IIIB extremity soft tissue sarcoma: long-term results from a single institution J Clin Oncol 15 12 1997 3481 3487
10. Early Breast Cancer Trialists' Collaborative Group Polychemotherapy for early breast cancer: an overview of the randomised trials Lancet 352 9132 1998 930 942
11. C.G. Moertel, T.R. Fleming, and J.S. Macdonald Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report Ann Intern Med 122 5 1995 321 326
12. C.S. Trovik, H.C. Bauer, and T.A. Alvegard Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register Eur J Cancer 36 6 2000 710 716
13. P.W. Pisters, D.H. Leung, and J. Woodruff Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities J Clin Oncol 14 5 1996 1679 1689
14. G.K. Zagars, M.T. Ballo, and P.W. Pisters Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 225 patients Cancer 97 10 2003 2530 2543
15. C.H. Gerrand, R.S. Bell, and J.S. Wunder The influence of anatomic location on outcome in patients with soft tissue sarcoma of the extremity Cancer 97 2 2003 485 492
16. S. Vraa, J. Keller, and O.S. Nielsen Prognostic factors in soft tissue sarcomas: the Aarhus experience Eur J Cancer 34 12 1998 1876 1882
17. C. Collin, J. Godbold, and S. Hajdu Localized extremity soft tissue sarcoma: an analysis of factors affecting survival J Clin Oncol 5 4 1987 601 612
18. J.J. Gaynor, C.C. Tan, and E.S. Casper Refinement of clinicopathologic staging for localized soft tissue sarcoma of the extremity: a study of 423 adults J Clin Oncol 10 8 1992 1317 1329
19. S. Vraa, J. Keller, and O.S. Nielsen Soft-tissue sarcoma of the thigh: surgical margin influences local recurrence but not survival in 152 patients Acta Orthop Scand 72 1 2001 72 77
20. M.D. McKee, D.F. Liu, and J.J. Brooks The prognostic significance of margin width for extremity and trunk sarcoma J Surg Oncol 85 2 2004 68 76
21. A.T. Stotter, R.P. A'Hern, and C. Fisher The influence of local recurrence of extremity soft tissue sarcoma on metastasis and survival Cancer 65 5 1990 1119 1129
22. American Joint Committee on Cancer Cancer staging manual 6th edition 2002 Springer New York
23. M.W. Kattan, D.H. Leung, and M.F. Brennan Postoperative nomogram for 12-year sarcoma-specific death J Clin Oncol 20 3 2002 791 796
24. F.C. Eilber, M.F. Brennan, and F.R. Eilber Validation of the postoperative nomogram for 12-year sarcoma-specific mortality Cancer 101 10 2004 2270 2275
25. J.B. Fleming, R.S. Berman, and S.C. Cheng Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas J Clin Oncol 17 9 1999 2772 2780
26. V.H. Bramwell, H.T. Mouridsen, and J.H. Mulder Carminomycin vs adriamycin in advanced soft tissue sarcomas: an EORTC randomised phase II study Eur J Cancer Clin Oncol 19 8 1983 1097 1104
27. E.C. Borden, D.A. Amato, and C. Rosenbaum Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas J Clin Oncol 5 6 1987 840 850
28. H.T. Mouridsen, L. Bastholt, and R. Somers Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma Group Eur J Cancer Clin Oncol 23 10 1987 1477 1483
29. I. Judson, J.A. Radford, and M. Harris Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group Eur J Cancer 37 7 2001 870 877
30. O.S. Nielsen, P. Dombernowsky, and H. Mouridsen High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group Br J Cancer 78 12 1998 1634 1639
31. K.H. Antman, L. Ryan, and A. Elias Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma J Clin Oncol 7 1 1989 126 131
32. V.H. Bramwell, H.T. Mouridsen, and A. Santoro Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma Group Cancer Chemother Pharmacol 31 Suppl 2 1993 S180 S184
33. R.S. Benjamin, S.S. Legha, and S.R. Patel Single-agent ifosfamide studies in sarcomas of soft tissue and bone: the M.D. Anderson experience Cancer Chemother Pharmacol 31 Suppl 2 1993 S174 S179
34. J.H. Edmonson, L.M. Ryan, and R.H. Blum Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas J Clin Oncol 11 7 1993 1269 1275
35. A. Le Cesne, I. Judson, and D. Crowther Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: a trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group J Clin Oncol 18 14 2000 2676 2684
36. J.A. Gottlieb, R.S. Benjamin, and L.H. Baker Role of DTIC (NSC-45388) in the chemotherapy of sarcomas Cancer Treat Rep 60 2 1976 199 203
37. P. Picci, G. Bacci, and F. Gherlinzoni Results of randomized trial for the treatment of localized soft tissue tumors (STS) of the extremities in adult patients J.R. Ryan L.H. Baker Recent concepts in sarcoma treatment 1988 Kluwer Academic Publishers Dordrecht (The Netherlands) 144 148
38. R.S. Benjamin, T.O. Terjanian, and C.J. Fenoglio The importance of combination chemotherapy for adjuvant treatment of high-risk patients with soft- tissue sarcomas of the extremities S.E. Salmon Adjuvant therapy of cancer V 1987 Grune and Stratton Orlando (FL) 735 744
39. S.A. Rosenberg, J. Tepper, and E. Glatstein Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities Cancer 52 3 1983 424 434
40. A.E. Chang, T. Kinsella, and E. Glatstein Adjuvant chemotherapy for patients with high-grade soft-tissue sarcomas of the extremity J Clin Oncol 6 9 1988 1491 1500
41. S. Frustaci, F. Gherlinzoni, and A. De Paoli Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial J Clin Oncol 19 5 2001 1238 1247
42. S. Frustaci, A. De Paoli, and E. Bidoli Ifosfamide in the adjuvant therapy of soft tissue sarcomas Oncology 65 Suppl 2 2003 80 84
43. F.R. Eilber, A.E. Giuliano, and J.F. Huth A randomized prospective trial using postoperative adjuvant chemotherapy (adriamycin) in high-grade extremity soft-tissue sarcoma Am J Clin Oncol 11 1 1988 39 45
44. T.A. Alvegard, H. Sigurdsson, and H. Mouridsen Adjuvant chemotherapy with doxorubicin in high-grade soft tissue sarcoma: a randomized trial of the Scandinavian Sarcoma Group J Clin Oncol 7 10 1989 1504 1513
45. L.H. Baker Adjuvant therapy for soft tissue sarcomas J.R. Ryan L.H. Baker Recent concepts in sarcoma treatment 1988 Kluwer Academic Publishers Dordrecht (The Netherlands) 130 135
46. K. Antman, L. Ryan, and E. Borden Pooled results from three randomized adjuvant studies of doxorubicin versus observation in soft tissue sarcoma: 10 year results and review of the literature S.E. Salmon Adjuvant therapy of cancer VI 1990 WB Saunders Philadelphia 529 543
47. V. Bramwell, J. Rouesse, and W. Steward Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma-reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group J Clin Oncol 12 6 1994 1137 1149
48. A. Ravaud, N.B. Bui, and J.M. Coindre Adjuvant chemotherapy with Cyvadic in high risk soft tissue sarcoma: a randomized prospective trial S.E. Salmon Adjuvant therapy of cancer VI 1990 WB Saunders Philadelphia 556 566
49. J.H. Edmonson, T.R. Fleming, and J.C. Ivins Randomized study of systemic chemotherapy following complete excision of nonosseous sarcomas J Clin Oncol 2 12 1984 1390 1396
50. G.W. Jones, M. Chouinard, and M. Patel Adjuvant adriamycin (doxorubicin) in adult patients with soft tissue sarcomas: a systematic overview and quantitative meta-analysis Clin Invest Med 14 Suppl 19 1991 A772
51. M.M. Zalupski, J.R. Ryan, and M.E. Hussein Defining the role of adjuvant chemotherapy for patients with soft tissue sarcoma of the extremities S.E. Salmon Adjuvant therapy of cancer VII 1993 JB Lippincott Philadelphia 385 392
52. J.F. Tierney, V. Mosseri, and L.A. Stewart Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials Br J Cancer 72 2 1995 469 475
53. T. Brodowicz, E. Schameis, and J. Widder Intensified adjuvant IFADIC chemotherapy for adult soft tissue sarcoma: a prospective randomized feasibility trial Sarcoma 4 2000 151 160
54. R. Petrioli, A. Coratti, and P. Correale Adjuvant epirubicin with or without ifosfamide for adult soft-tissue sarcoma Am J Clin Oncol 25 5 2002 468 473
55. E. Gortzak, A. Azzarelli, and J. Buesa A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma Eur J Cancer 37 9 2001 1096 1103
56. T.F. DeLaney, I.J. Spiro, and H.D. Suit Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas Int J Radiat Oncol Biol Phys 56 4 2003 1117 1127
57. S.R. Grobmyer, R.G. Maki, and G.D. Demetri Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma Ann Oncol 15 11 2004 1667 1672
58. C.M. Pezzi, R.E. Pollock, and H.L. Evans Preoperative chemotherapy for soft-tissue sarcomas of the extremities Ann Surg 211 4 1990 476 481
59. J.N. Cormier, X. Huang, and Y. Xing Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes J Clin Oncol 22 22 2004 4567 4574
60. F.C. Eilber, F.R. Eilber, and J. Eckardt The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma Ann Surg 240 4 2004 686 695